About 918 results for "usfda"

Glenmark gets USFDA approval for headache drug

"Glenmark will commence distribution of the product immediately," the Mumbai-based firm said. Economic Times, 4 days ago

Glenmark gets USFDA nod for Zolmitriptan tablets - Myiris, 4 days ago

Glenmark gets USFDA nod for headache drug - Business Line, 4 days ago

More from: Equities.com, Reuters UK...and 73 other sources

[x]

See all (81) images for "usfda"
ZeeNews.com, 4 days ago	Business Today India, 2 weeks ago	India TV, 2 weeks ago	Moneycontrol.com, 2 weeks ago	Moneycontrol.com, 2 weeks ago
GMA News.tv, 2 weeks ago	Moneycontrol.com, 3 weeks ago	ZeeNews.com, 3 weeks ago	Indian Express, 1 month ago	ZeeNews.com, 1 month ago

See all (81) images for "usfda"

left

right

Glenmark gets USFDA approval for headache drug

ZeeNews.com, 4 days ago

Glenmark Pharma's arm receives final ANDA approvals for Zolmitriptan Tablets from USFDA

Glenmark Generics Inc, USA, a subsidiary of Glenmark Pharmaceuticals has been granted final abbreviated new drug approvals (ANDA's) from the United States Food and Drug Administration (USFDA) for Zolmitriptan Tablets, 2.5 and 5mg and Zolmitriptan ...

Indian-Commodity, 4 days ago Glenmark Generics receives final ANDA approvals for Zolmitriptan tablets Money Control, 4 days ago Glenmark confirms patent challenge for its generic version of FINACEA Money Control, 2 months ago

ZeeNews.com

Piramal Enterprises receives nod from USFDA for anti-diabetes molecule

Piramal Enterprises has received approval from US Food and Drug Administration (USFDA) for its investigational new drug (IND), P11187, which aims to target diabetes. This will enable the company to initiate a Phase I clinical trial of new chemical ...

Indian-Commodity, 4 days ago Piramal gets USDFA nod for anti-diabetic molecule Economic Times, 5 days ago Piramal Enterprises gets US nod for anti-diabetes molecule Smart Investor, 5 days ago Piramal Enterprises gets USDFA nod for anti-diabetic molecule ZeeNews.com, 5 days ago

SPARC receives negative response from USFDA on Levetiracetam NDA

Sun Pharma Advanced Research Company (SPARC) has received a complete response letter from the US Food and Drug Administration (USFDA) on its New Drug Application (NDA) for Levetiracetam Extended-release tablets, 1000mg and 1500mg, an anti-epileptic ...

Indian-Commodity, 1 week ago Sun Pharma gets USFDA response on Levetiracetam NDA India Infoline, 1 week ago SPARC dips as FDA rejects Levetiracetam NDA Smart Investor, 1 week ago Stocks to watch: Sun Pharma, Balaji Tele and SpiceJet Hindu Business Line, 2 weeks ago

Aurobindo Pharma rises on receiving USFDA nod for Tamsulosin HCL Capsules and Pediatric

Aurobindo Pharma is currently trading at Rs. 198.00, up by 1.45 points or 0.74% from its previous closing of Rs. 196.55 on the BSE. The scrip opened at Rs. 198.50 and has touched a high and low of Rs. 199.25 and Rs. 197.80 respectively. So far ...

Indian-Commodity, 1 week ago

Indoco receives ANDA approval for Glimepiride tablets from USFDA

The approval is for Glimepiride 1mg, 2mg and 4mg tablets which are prescribed for type-2 diabetes patients to enhance glycemic control Indoco Remedies has received the USFDA approval for its Abbreviated New Drug Application (ANDA) for Glimepiride ...

Express Pharma, 2 weeks ago

Orchid's Cephalosporin API unit clears USFDA inspection; stock jumps 5%

Orchid Chemicals & Pharmaceuticals , an Indian pharmaceutical company based in Chennai, announced that Orchid's Cephalosporin API manufacturing complex located in Alathur, Chennai has successfully cleared the USFDA inspection that it went through. The ...

Myiris, 1 month ago Orchid surges 5% after passing USFDA inspection for Cephalosporin API unit Myiris, 1 month ago

Sequent Scientific receives USFDA approval

Sequent Scientific has received US FDA approval for its API Drug Manufacturing facility at Mangalore, Karnataka.

Money Control, 2 weeks ago Sequent Scientific receives US FDA Approval for ITS API Drug Manufacturing Facility at Mangalore Equity Bulls, 2 weeks ago Sequent received US FDA approval for its API drug manufacturing facility at Mangalore [Bangalore] Pharmaceutical & Medical Packaging News, 2 weeks ago

Hikal receives USFDA approval for its pharmaceutical manufacturing site in Gujarat

Hikal's second manufacturing facility located at Panoli, Bharuch district in the state of Gujarat, which manufactures pharmaceutical ingredients, intermediates and regulated starting materials has successfully completed a USFDA audit and received ...

Indian-Commodity, 3 weeks ago Hikal shines on receiving USFDA approval for its pharmaceutical manufacturing site in Gujarat Indian-Commodity, 3 weeks ago Hikal gets FDA nod for Gujarat facility Business Line, 3 weeks ago

Moneycontrol.com

Orchid Chemicals clear USFDA inspection

Orchid Chemicals Pharmaceuticals Ltd has informed BSE that Orchid's Cephalosporin API manufacturing complex located in Alathur, Chennai has successfully cleared the USFDA inspection that it went through.

Money Control, 1 month ago Orchid Chemicals & Pharmaceuticals' Alathur Unit clears USFDA inspection Equity Bulls, 1 month ago Orchid Chemicals & Pharmaceuticals jumps on clearing USFDA inspection Arihant Capital, 1 month ago Allecra deal to infuse USD 1m in cash: Orchid Chemicals Moneycontrol.com, 1 month ago

Prev | Next